Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

NCT00005057 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: adenovirus RSV-TK
DRUG: ganciclovir

Sponsor

National Human Genome Research Institute (NHGRI)

Collaborators

[object Object]